| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 01/17/2002 | CA2411160A1 Colchinol derivatives as vascular damaging agents |
| 01/16/2002 | EP1172356A1 Process for producing N-acylnitroaniline derivative |
| 01/16/2002 | EP1171432A1 Adamantane derivatives |
| 01/16/2002 | EP1171423A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 01/16/2002 | EP1171419A1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor |
| 01/16/2002 | EP1171416A1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 01/15/2002 | US6339164 C2 substituted phenyl taxane derivatives and pharmaceutical compositions containing them |
| 01/10/2002 | WO2002002578A1 Ferrocenyl diphosphines and their use |
| 01/10/2002 | WO2002002520A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002510A1 Purified polyoxypropylene fatty acid isopropanolamide surfactants, production thereof and detergent compositions containing the surfactants |
| 01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2001068586A3 α4β1 AND α4β7 INTEGRIN INHIBITORS |
| 01/10/2002 | WO2001052900A3 Novel orthogonally protected amino acid chelators for biomedical applications |
| 01/10/2002 | WO2001023346A3 Process for phenylacetic acid derivatives |
| 01/10/2002 | US20020004522 Nervous system disorders |
| 01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | CA2410972A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410680A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1169699A1 Lubricant for magnetic recording medium and use thereof |
| 01/09/2002 | EP0929624B1 Surfactant-containing formulations |
| 01/09/2002 | EP0778263B1 Benzene compound and medicinal use thereof |
| 01/09/2002 | CN1330676A Highly branched oligomers, process for their preparation and application thereof |
| 01/09/2002 | CN1330630A 7-aryl-6(z) heptantriene acid vitamin A amide as apoptosis inducing compounds and their use as anti-cancer agents |
| 01/09/2002 | CN1330629A Novel 2-akoxybenzylamine derivatives and their use as medicines for treating schizophrenia |
| 01/08/2002 | US6337423 Bind to voltage-gated sodium ion channels to modulate activity |
| 01/08/2002 | US6337351 Pharmaceutical compositions and methods for use |
| 01/08/2002 | US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 01/08/2002 | US6337150 Light-emitting compound and display device adopting light-emitting compound as color-developing substance |
| 01/08/2002 | US6337064 Used as contrast agent in magnetic resonance imaging, medical diagnosis |
| 01/03/2002 | WO2002000920A2 Ingestibles possessing intrinsic color change |
| 01/03/2002 | WO2002000609A2 2,6,7-substituted tetralines useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 01/03/2002 | WO2002000593A2 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 01/03/2002 | WO2002000590A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 01/03/2002 | WO2002000167A2 Modified forms of pharmacologically active agents and uses therefor |
| 01/03/2002 | WO2001045836A3 Molecules derived from mechanism based drug design |
| 01/03/2002 | US20020002296 Cytoprotective Compounds |
| 01/03/2002 | US20020002292 C7 taxane derivatives and pharmaceutical compositions containing them |
| 01/03/2002 | US20020002281 Method of preparing amino carboxylic acids |
| 01/03/2002 | US20020002200 Novel diphenylethylene compounds |
| 01/03/2002 | US20020002199 Suitable for treating type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 01/03/2002 | US20020002196 Administering a patient an effective amount of hydroxyeicosatetraenoic acid related compounds to treat the dry eye |
| 01/03/2002 | US20020001591 Compositions for the delivery of antigens |
| 01/03/2002 | DE10029139A1 Verfahren zur Herstellung von Amiden oder Estern A process for producing amides or esters |
| 01/03/2002 | CA2414529A1 Ingestibles possessing intrinsic color change |
| 01/03/2002 | CA2414150A1 Modified forms of nonsteroidal anti-inflammatory drugs and uses thereof |
| 01/03/2002 | CA2411162A1 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 01/02/2002 | EP1167346A1 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient |
| 01/02/2002 | EP1166766A1 External preparation compositions |
| 01/02/2002 | EP1165495A1 Resorcinol derivatives |
| 01/02/2002 | EP1165487A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 01/02/2002 | EP1165064A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 01/01/2002 | US6335444 Amino alcohol derivative and method for preparing the same |
| 01/01/2002 | US6335375 Concentrated fluid aqueous-alcoholic compositions of hydrogenated coconut or palm kernel oil alkylamidopropylbetaines |
| 01/01/2002 | US6335370 Fluid concentrated hydroalcoholic compositions of copra or oil palm alkyl-amidopropylbetains |
| 01/01/2002 | US6335366 A prostaglandin e2 antagonist or agonist which comprises a naphthylhydroxy derivatives or naphthyloxyalkylene derivatives or nontoxic salts |
| 01/01/2002 | US6335362 Antitumor and anticarcinogenic agents for leukemia |
| 01/01/2002 | US6335303 Effective in polymerization of alpha olefins to high molecular weight polymers |
| 01/01/2002 | CA2093789C Bi-aromatic compounds and their use in human and veterinary medicine and in cosmetic preparations |
| 12/27/2001 | WO2001098257A1 NOVEL β-HYDROXYAMIDES |
| 12/27/2001 | WO2001098256A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 12/27/2001 | WO2001098245A2 Triphenyl compounds as interleukin-4 antagonists |
| 12/27/2001 | WO2001028979A3 Inhibitors of neuraminidases |
| 12/27/2001 | US20010056211 Adrenergic blocking agent |
| 12/27/2001 | US20010056208 Method and agents for permanently styling hair, with a base consisting of n,n-disubstituted mercaptoacetamides, and method for producing said mercaptoacetamides |
| 12/27/2001 | US20010056207 Nitro-benzamide useful as anti-arrhythmic agent |
| 12/26/2001 | CN1327953A Process for treating waste liquid of furaldehyde and recovering butyl acetate, ammonium sulfate, ammonium acetate, acetamide and acetonitrile |
| 12/25/2001 | US6333358 Aryloxyaniline derivatives |
| 12/20/2001 | WO2001097217A2 Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition |
| 12/20/2001 | WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | WO2001096282A1 Method for producing amides or esters |
| 12/20/2001 | WO2001095720A1 Use of amine compounds with improved biodegradability as adjuvants for pesticides and fertilisers |
| 12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
| 12/20/2001 | US20010053863 Curable allyl homopolymer |
| 12/20/2001 | US20010053774 Non-steroidal ligands for the estrogen receptor |
| 12/20/2001 | CA2412618A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | CA2412615A1 Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition |
| 12/20/2001 | CA2407568A1 Use of amine compounds with improved biodegradability as adjuvants for pesticides and fertilisers |
| 12/19/2001 | EP1163210A1 Rosin amine anti-fouling agents |
| 12/19/2001 | EP1163208A2 Caspase inhibitors and uses thereof |
| 12/19/2001 | EP1163194A1 Selective nitrogen functionalisation of organic compounds |
| 12/19/2001 | EP0951496B1 Alkyd and aralkyd derivatives of phenolic polymers |
| 12/19/2001 | CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/19/2001 | CN1326926A Preparing D-(-)-Su's 1-R-substituted phenyl-2-difluoro acetoamino-3-fluoro-1-propanol from L type substituted phenyl serine ester |
| 12/19/2001 | CN1326925A Method for coproducing trichloromethane and N,N-dimethyl formyl amide with chlorine oil and dimethyl amine |
| 12/18/2001 | USRE37478 1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics |
| 12/18/2001 | US6331640 Diaminopropionic acid derivatives |
| 12/18/2001 | US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control |
| 12/18/2001 | US6331570 Active enantiomer of RARγ-specific agonist |
| 12/18/2001 | US6331566 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use |
| 12/18/2001 | US6331564 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 12/18/2001 | US6331318 Carbon-substituted diketopiperazine delivery systems |
| 12/18/2001 | CA2031897C Carbamoyl derivatives |
| 12/13/2001 | WO2001094524A2 Highly concentrated coconut amido propyl betaine |
| 12/13/2001 | WO2001094359A1 Chiral ligands for asymmetric catalysis |